Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells

被引:0
|
作者
A Ray
D S Das
Y Song
P Richardson
N C Munshi
D Chauhan
K C Anderson
机构
[1] The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center,Department of Medical Oncology
[2] Dana-Farber Cancer Institute,undefined
[3] Harvard Medical School,undefined
来源
Leukemia | 2015年 / 29卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1441 / 1444
页数:3
相关论文
共 50 条
  • [1] Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells
    Ray, A.
    Das, D. S.
    Song, Y.
    Richardson, P.
    Munshi, N. C.
    Chauhan, D.
    Anderson, K. C.
    LEUKEMIA, 2015, 29 (06) : 1441 - 1444
  • [2] The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
    Jun Tang
    Jia Xin Yu
    Vanessa M. Hubbard-Lucey
    Svetoslav T. Neftelinov
    Jeffrey P. Hodge
    Yunqing Lin
    Nature Reviews Drug Discovery, 2018, 17 : 854 - 855
  • [3] The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
    Tang, Jun
    Yu, Jia Xin
    Lin, Yunqing
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) : 854 - 854
  • [4] Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma
    Ameli, Fereshteh
    Shajareh, Elham
    Mokhtari, Maral
    Kosari, Farid
    BMC CANCER, 2022, 22 (01)
  • [5] Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma
    Fereshteh Ameli
    Elham Shajareh
    Maral Mokhtari
    Farid Kosari
    BMC Cancer, 22
  • [6] Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients
    Xing, Xiaofang
    Guo, Jianping
    Wen, Xianzi
    Ding, Guangyu
    Li, Bo
    Dong, Bin
    Feng, Qin
    Li, Shen
    Zhang, Jian
    Cheng, Xiaojing
    Guo, Ting
    Du, Hong
    Hu, Ying
    Wang, Xiaohong
    Li, Lin
    Li, Qingda
    Xie, Meng
    Li, Liting
    Gao, Xiangyu
    Shan, Fei
    Li, Ziyu
    Ying, Xiaomin
    Zhou, Tao
    Wang, Jiping
    Ji, Jiafu
    ONCOIMMUNOLOGY, 2018, 7 (03):
  • [7] PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells
    Guo, Yanan
    Feng, Xiaoli
    Jiang, Yang
    Shi, Xiaoyun
    Xing, Xiangling
    Liu, Xiaoli
    Li, Nailin
    Fadeel, Bengt
    Zheng, Chengyun
    ONCOTARGET, 2016, 7 (30) : 48360 - 48374
  • [8] Polymeric PD1/PDL1 bispecific antibody enhances immune checkpoint blockade therapy
    Xue, Fuxin
    Ren, Xitong
    Kong, Chaoying
    Wang, Jianfeng
    Liu, Linlin
    Hu, Junli
    Shen, Na
    Tang, Zhaohui
    MATERIALS TODAY BIO, 2024, 28
  • [9] The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
    Quatrini, Linda
    Mariotti, Francesca Romana
    Munari, Enrico
    Tumino, Nicola
    Vacca, Paola
    Moretta, Lorenzo
    CANCERS, 2020, 12 (11) : 1 - 21
  • [10] Biology of plasmacytoid dendritic cells and natural killer cells in HIV-1 infection
    Lakshmanan, Viswanathan
    Alter, Galit
    Altfeld, Marcus
    Bhardwaj, Nina
    CURRENT OPINION IN HIV AND AIDS, 2007, 2 (03) : 189 - 200